Shinyurigaoka General Hospital

Kawasaki 215-0026

1 studies enrolling now · 2 studies all time

What they study most

Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Peripheral Arterial Disease

Studies at this site

• Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease — Recruiting now
• Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis — Stopped early